1. Most Discussed
  2. Gainers & Losers
SLT 0.7¢

some facts to think about

  1. Billy Gatess

    5,609 Posts.

    This provides some frame of
    reference.

    Select’s ultimate
    valuation will depend on the
    success in commercialising its I.P.
    The risk profile is somewhat
    reduced by the near-term
    commercial prospects of the
    diagnostics.

    Cellestis is currently
    the closest comparable company
    to SLT with a current market cap.
    of approx $120 million and current
    sales of less than $1 million.




    Hepatitis details

    Hepatitis A (HAV)
    Occurrence: Global; 1.5 million cases
    of clinical hepatitis each year
    Transmission: contact, food & water
    Health effects: relatively benign

    Hepatitis B (HBV)
    Characteristics: Acute liver infection
    Occurrence: 1.5 million clinical cases
    worldwide yearly; vaccine preventable
    Transmission: close personal contact
    and contaminated food and water
    Effects: contributes to serious infection

    Hepatitis C (HCV)
    Characteristics: Acute liver infection
    Spread: estimated 170 million people
    globally; no vaccine or ‘POC’ diagnosis
    Transmission: unscreened blood
    transfusions and re-use of needles

    Hepatitis D (HDV) (worldwide),
    present with HBV, sexually transmitted

    Hepatitis E (HEV)
    Occurrence: globally widespread
    Transmission: water, & personal contact
    Health effects: Relatively benign, but
    can cause death in pregnant women

DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.

Top

Thank you for visiting HotCopper

We have detected that you are running ad blocking software.


HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.